TAIWAN · TWSE / TPEx
SOFIVA
慧智 · 6615 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$33.151 month -1.6% · 1 year -1.0%
Directors and supervisors hold3,030,50014.0% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold2,893,00013.4% of shares issued
Revenue, 2026-09+1.8%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 蘇怡寧 | Chairman · Major shareholder (10%+) | 464,500 | 464,500 | 2.15% | — | 6,497,500 |
| 怡睿投資股份有限公司 | Director · Major shareholder (10%+) | 2,428,500 | 2,428,500 | 11.25% | — | — |
| 陳君蕙 | Director (corporate representative) | — | 96,000 | 0.44% | — | 464,500 |
| 陳亭宇 | Director | 110,500 | 110,500 | 0.51% | — | — |
| 李麗娟 | Director | 27,000 | 27,000 | 0.13% | — | 20,000 |
| 施汎泉 | Independent director | — | 0 | — | — | — |
| 潘宜珊 | Independent director | — | 0 | — | — | — |
| 李建南 | Independent director | — | 0 | — | — | — |
| 洪加政 | President | — | 489,000 | 2.26% | — | — |
| 張伏見 | Chief financial officer · Chief accountant | — | 0 | — | — | — |